Allspring Global Investments Holdings LLC Boosts Position in Humana Inc. (NYSE:HUM)

Allspring Global Investments Holdings LLC boosted its position in shares of Humana Inc. (NYSE:HUM - Free Report) by 11.6% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 758,002 shares of the insurance provider's stock after acquiring an additional 79,031 shares during the quarter. Allspring Global Investments Holdings LLC owned 0.63% of Humana worth $200,673,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the company. Retirement Planning Co of New England Inc. increased its position in Humana by 4.7% during the fourth quarter. Retirement Planning Co of New England Inc. now owns 966 shares of the insurance provider's stock valued at $245,000 after acquiring an additional 43 shares during the last quarter. LFA Lugano Financial Advisors SA increased its position in Humana by 56.3% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock valued at $32,000 after acquiring an additional 45 shares during the last quarter. Achmea Investment Management B.V. increased its position in Humana by 0.5% during the first quarter. Achmea Investment Management B.V. now owns 10,379 shares of the insurance provider's stock valued at $2,746,000 after acquiring an additional 49 shares during the last quarter. Beech Hill Advisors Inc. increased its position in Humana by 6.1% during the first quarter. Beech Hill Advisors Inc. now owns 865 shares of the insurance provider's stock valued at $229,000 after acquiring an additional 50 shares during the last quarter. Finally, Oregon Public Employees Retirement Fund increased its position in Humana by 0.6% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 10,316 shares of the insurance provider's stock valued at $2,617,000 after acquiring an additional 62 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company's stock.

Humana Price Performance

Shares of Humana stock opened at $241.82 on Friday. The stock has a 50 day moving average of $241.94 and a 200 day moving average of $259.43. Humana Inc. has a 12 month low of $212.45 and a 12 month high of $406.46. The firm has a market cap of $29.18 billion, a PE ratio of 17.10, a PEG ratio of 1.81 and a beta of 0.43. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.71.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $11.58 EPS for the quarter, beating analysts' consensus estimates of $10.07 by $1.51. Humana had a return on equity of 14.47% and a net margin of 1.42%. The company had revenue of $32.11 billion during the quarter, compared to analyst estimates of $32 billion. During the same period in the prior year, the company earned $7.23 earnings per share. The firm's revenue was up 8.4% on a year-over-year basis. On average, research analysts expect that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be issued a $0.885 dividend. The ex-dividend date is Friday, June 27th. This represents a $3.54 annualized dividend and a dividend yield of 1.46%. Humana's payout ratio is 25.04%.

Analysts Set New Price Targets

HUM has been the subject of a number of analyst reports. Truist Financial set a $280.00 price target on Humana and gave the stock a "hold" rating in a research report on Tuesday, June 17th. Oppenheimer upped their price target on Humana from $300.00 to $310.00 and gave the stock an "outperform" rating in a research report on Thursday, May 1st. Wall Street Zen upgraded Humana from a "hold" rating to a "buy" rating in a research report on Friday. Mizuho upped their price target on Humana from $305.00 to $316.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Finally, Barclays set a $268.00 price target on Humana and gave the stock an "equal weight" rating in a research report on Thursday, June 12th. Sixteen investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to MarketBeat, Humana currently has an average rating of "Hold" and a consensus target price of $280.76.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.